Korro Bio, Inc. (KRRO)
12.19
+0.57
(+4.91%)
USD |
NASDAQ |
Sep 04, 13:15
Korro Bio 1 Year Total Returns (Daily) : -55.37% for Sept. 3, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 03, 2026 | -55.37% |
| September 02, 2026 | -46.09% |
| September 01, 2026 | -46.97% |
| August 31, 2026 | -45.88% |
| August 28, 2026 | -45.46% |
| August 27, 2026 | -38.55% |
| August 26, 2026 | -32.48% |
| August 25, 2026 | -31.59% |
| August 24, 2026 | -34.78% |
| August 21, 2026 | -35.86% |
| August 20, 2026 | -32.75% |
| August 19, 2026 | -27.12% |
| August 18, 2026 | -32.96% |
| August 17, 2026 | -35.14% |
| August 14, 2026 | -33.20% |
| August 13, 2026 | -29.79% |
| August 12, 2026 | -16.51% |
| August 11, 2026 | -11.50% |
| August 10, 2026 | -15.69% |
| August 07, 2026 | -16.46% |
| August 06, 2026 | -22.80% |
| August 05, 2026 | -27.76% |
| August 04, 2026 | -26.73% |
| August 03, 2026 | -22.45% |
| July 31, 2026 | -30.68% |
| Date | Value |
|---|---|
| July 30, 2026 | -35.73% |
| July 29, 2026 | -33.58% |
| July 28, 2026 | -32.74% |
| July 27, 2026 | -33.04% |
| July 24, 2026 | -33.08% |
| July 23, 2026 | -31.57% |
| July 22, 2026 | -17.55% |
| July 21, 2026 | -10.34% |
| July 20, 2026 | -15.87% |
| July 17, 2026 | -11.42% |
| July 16, 2026 | -6.69% |
| July 15, 2026 | 2.92% |
| July 14, 2026 | 2.35% |
| July 13, 2026 | 6.22% |
| July 10, 2026 | 7.14% |
| July 09, 2026 | -2.85% |
| July 08, 2026 | 8.39% |
| July 07, 2026 | 15.18% |
| July 06, 2026 | 5.32% |
| July 02, 2026 | 6.95% |
| July 01, 2026 | 6.89% |
| June 30, 2026 | 5.52% |
| June 29, 2026 | 9.68% |
| June 26, 2026 | 2.92% |
| June 25, 2026 | 1.93% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 211.1% |
| Oncolytics Biotech, Inc. | -26.16% |
| Sangamo Therapeutics, Inc. | -68.88% |
| Sarepta Therapeutics, Inc. | 21.32% |
| Anixa Biosciences, Inc. | 2.01% |